Zhong K, Cummings J. A critical review of brexpiprazole oral tablets as the first drug approved to treat agitation symptoms associated with dementia due to Alzheimer's disease. Expert Rev Neurother. 2025 Jan;25(1):5-13. Epub 2024 Sep 29 PubMed.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.

This paper appears in the following:

Therapeutics

  1. Brexpiprazole